These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21900196)

  • 1. Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation.
    Kawano Y; Kim HT; Matsuoka K; Bascug G; McDonough S; Ho VT; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J
    Blood; 2011 Nov; 118(18):5021-30. PubMed ID: 21900196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.
    Soares MV; Azevedo RI; Ferreira IA; Bucar S; Ribeiro AC; Vieira A; Pereira PNG; Ribeiro RM; Ligeiro D; Alho AC; Soares AS; Camacho N; Martins C; Lourenço F; Moreno R; Ritz J; Lacerda JF
    Front Immunol; 2019; 10():334. PubMed ID: 30894856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells.
    Clark FJ; Gregg R; Piper K; Dunnion D; Freeman L; Griffiths M; Begum G; Mahendra P; Craddock C; Moss P; Chakraverty R
    Blood; 2004 Mar; 103(6):2410-6. PubMed ID: 14604970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Hu Y; Cui Q; Ye Y; Luo Y; Tan Y; Shi J; Huang H
    Hematol Oncol; 2017 Mar; 35(1):118-124. PubMed ID: 26439896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.
    Zorn E; Kim HT; Lee SJ; Floyd BH; Litsa D; Arumugarajah S; Bellucci R; Alyea EP; Antin JH; Soiffer RJ; Ritz J
    Blood; 2005 Oct; 106(8):2903-11. PubMed ID: 15972448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.
    Bremm M; Huenecke S; Lehrnbecher T; Ponstingl E; Mueller R; Heinze A; Bug G; Quaiser A; Kapinsky M; Brehm C; Bader P; Schneider G; Klingebiel T; Koehl U
    J Immunol Methods; 2011 Oct; 373(1-2):36-44. PubMed ID: 21839739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].
    Yang K; Fan ZP; Liu QF; Zhang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):537-41. PubMed ID: 18495584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Sirolimus on Immune Reconstitution Following Myeloablative Allogeneic Stem Cell Transplantation: An Ancillary Analysis of a Randomized Controlled Trial Comparing Tacrolimus/Sirolimus and Tacrolimus/Methotrexate (Blood and Marrow Transplant Clinical Trials Network/BMT CTN 0402).
    Gooptu M; Kim HT; Howard A; Choi SW; Soiffer RJ; Antin JH; Ritz J; Cutler CS
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2143-2151. PubMed ID: 31271885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturation and Phenotypic Heterogeneity of Human CD4+ Regulatory T Cells From Birth to Adulthood and After Allogeneic Stem Cell Transplantation.
    Matos TR; Hirakawa M; Alho AC; Neleman L; Graca L; Ritz J
    Front Immunol; 2020; 11():570550. PubMed ID: 33537026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25highCD127low regulatory T cells in peripheral blood are not an independent factor for chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Perz JB; Gürel S; Schonland SO; Hegenbart U; Ho AD; Dreger P
    ScientificWorldJournal; 2012; 2012():606839. PubMed ID: 22666141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.
    Imanguli MM; Cowen EW; Rose J; Dhamala S; Swaim W; Lafond S; Yagi B; Gress RE; Pavletic SZ; Hakim FT
    Leukemia; 2014 Oct; 28(10):2016-27. PubMed ID: 24577531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD4+CD25+highFoxp3+CD62L+ regulatory T cells and invariant NKT cells in human allogeneic hematopoietic stem cell transplantation.
    Vela-Ojeda J; Montiel-Cervantes L; Granados-Lara P; Reyes-Maldonado E; García-Latorre E; Garcia-Chavez J; Majluf-Cruz A; Mayani H; Borbolla-Escoboza JR; Esparza MG
    Stem Cells Dev; 2010 Mar; 19(3):333-40. PubMed ID: 19919293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of CD25 expression on donor CD8+ and CD4+ T cells with graft-versus-host disease after donor lymphocyte infusions.
    Mutis T; Aarts-Riemens T; Verdonck LF
    Haematologica; 2005 Oct; 90(10):1389-95. PubMed ID: 16219576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation.
    Li Q; Zhai Z; Xu X; Shen Y; Zhang A; Sun Z; Liu H; Geng L; Wang Y
    Leuk Res; 2010 Sep; 34(9):1158-68. PubMed ID: 20409584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.
    Wolf D; Rumpold H; Koppelstätter C; Gastl GA; Steurer M; Mayer G; Gunsilius E; Tilg H; Wolf AM
    Cancer Immunol Immunother; 2006 Oct; 55(10):1198-208. PubMed ID: 16362412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthy-like CD4
    Schneider J; Kuhlmann L; Xiao Y; Raha S; Bernhardt G; Stadler M; Thol F; Heuser M; Eder M; Ganser A; Ravens S; Förster R; Prinz I; Koenecke C; Schultze-Florey CR
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease.
    Theil A; Tuve S; Oelschlägel U; Maiwald A; Döhler D; Oßmann D; Zenkel A; Wilhelm C; Middeke JM; Shayegi N; Trautmann-Grill K; von Bonin M; Platzbecker U; Ehninger G; Bonifacio E; Bornhäuser M
    Cytotherapy; 2015 Apr; 17(4):473-86. PubMed ID: 25573333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of pDCs, mDCs, γδT cells and regulatory T cells in association with graft versus host disease after hematopoietic stem cell transplantation.
    Watanabe N; Narita M; Furukawa T; Nakamura T; Yamahira A; Masuko M; Toba K; Fuse I; Aizawa Y; Takahashi M
    Int J Lab Hematol; 2011 Aug; 33(4):378-90. PubMed ID: 21692996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.